Ontruzant 420 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26F9KC9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,210
Award facts
- Contract value 100% obligated
- $33,210.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $33,210.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Oncotruzant 420 mg vials, with an ultimate completion date of January 8, 2026. This non-set-aside, competitively awarded contract represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. The contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania.
Oncotruzant is a biosimilar medication used in oncology treatment, reflecting DLA's ongoing pharmaceutical supply chain requirements for military healthcare systems. AmerisourceBergen, operating through its subsidiary and parent entity Cencora, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military treatment facilities and veteran healthcare programs. The award demonstrates the contractor's continued capability to fulfill federal medical supply needs through open competition and its established position as a preferred vendor for specialized pharmaceutical commodities within the military healthcare system.
Quick answers
Who was awarded contract SPE2DR26F9KC9?
SPE2DR26F9KC9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F9KC9 worth?
The government has obligated $33,210 on SPE2DR26F9KC9.
Is contract SPE2DR26F9KC9 an order under another contract?
Yes. SPE2DR26F9KC9 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9KC9 competed?
The extent of competition for SPE2DR26F9KC9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award